Anaphylaxis in Children and Adolescents: Greek Data Analysis from the European Anaphylaxis Registry (NORA).
anaphylaxis
anaphylaxis management
food allergy
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
30 Sep 2022
30 Sep 2022
Historique:
received:
14
08
2022
revised:
09
09
2022
accepted:
26
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
The European Anaphylaxis Registry (NORA) was designed in order to create a comprehensive Anaphylaxis Registry regarding anaphylactic reactions characteristics and management in several European countries, including Greece. This study aims to analyze Greek data obtained in the NORA framework and describe anaphylaxis' characteristics in this pediatric cohort. An online questionnaire was filled out by the Allergy Unit of the 2nd Pediatric Department of NKUA, regarding reported anaphylaxis characteristics. A total of 284 pediatric patients were analyzed. Patients were predominantly male. A previous, mild reaction (59.5%) to the same allergen was documented in 44.4% of patients. The most common system involved was skin and/or mucosa, followed by the respiratory system. Food was the most common eliciting factor (82.4%). First line treatment was most administered solely by a healthcare professional, followed by a lay person (38.7%). Auto injected adrenaline use by lay persons was third in frequency (29.2%). Most patients received post-reaction counseling and appropriate drug prescription. This study provides insight in anaphylactic cases' characteristics and management in a Greek pediatric cohort. A low rate of adrenaline autoinjector administration was noted in lay people; however, drug prescription and counseling following the reaction could help increase correct acute anaphylaxis management in the future.
Identifiants
pubmed: 36294753
pii: jpm12101614
doi: 10.3390/jpm12101614
pmc: PMC9604916
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Allergy. 2022 Feb;77(2):357-377
pubmed: 34343358
Front Immunol. 2017 May 29;8:614
pubmed: 28611774
Pediatr Allergy Immunol. 2011 Sep;22(6):568-74
pubmed: 21435004
Clin Exp Allergy. 2015 Jun;45(6):1027-39
pubmed: 25495512
Ann Allergy Asthma Immunol. 2014 Jun;112(6):560-2
pubmed: 24860922
Curr Allergy Asthma Rep. 2021 Apr 7;21(4):28
pubmed: 33825067
J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1898-1906.e1
pubmed: 29606638
Asian Pac J Allergy Immunol. 2017 Dec;35(4):212-219
pubmed: 27543730
Allergy. 2014 Oct;69(10):1397-404
pubmed: 24989080
Allergy Asthma Proc. 2021 May 1;42(3):e96-e100
pubmed: 33980345
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81
pubmed: 20176258
Pediatr Allergy Immunol. 2020 Nov;31(8):879-888
pubmed: 32519391
Pediatr Clin North Am. 2019 Oct;66(5):995-1005
pubmed: 31466687
J Investig Allergol Clin Immunol. 2019 Dec;29(6):461-463
pubmed: 31825314
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26:8-10
pubmed: 33236416
Pediatr Allergy Immunol. 2021 Aug;32(6):1278-1286
pubmed: 33774834
Curr Pediatr Rev. 2018;14(3):180-186
pubmed: 29732976
Allergy Asthma Proc. 2022 Jan 1;43(1):50-56
pubmed: 34983711
J Allergy Clin Immunol. 2016 Apr;137(4):1128-1137.e1
pubmed: 26806049
Biomed Res Int. 2020 Feb 27;2020:2014104
pubmed: 32190654
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1148-1156.e5
pubmed: 30737191
Lancet. 1977 Feb 26;1(8009):466-9
pubmed: 65572
Allergy. 2019 Jun;74(6):1063-1080
pubmed: 30688375
Allergol Immunopathol (Madr). 2012 Jan-Feb;40(1):31-6
pubmed: 21497010
Curr Treat Options Allergy. 2017;4(3):312-319
pubmed: 28890861
Eur Ann Allergy Clin Immunol. 2015 Nov;47(6):197-205
pubmed: 26549337
World Allergy Organ J. 2014 May 30;7(1):9
pubmed: 24920969
Clin Exp Allergy. 2015 Nov;45(11):1621-36
pubmed: 25495886
Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):331-5
pubmed: 22112535